[1]
2021. Dose-dependent effects of adalimumab in neonatal rats with hypoxia/reoxygenation-induced intestinal damage. Biomolecules and Biomedicine. 21, 1 (Feb. 2021), 33–38. DOI:https://doi.org/10.17305/bjbms.2020.4823.